Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Jeha, S' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 25 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Multani, AS; Worth, LL; Jeha, S; Chan, KW; Pathak, S
      Human bone marrow transplant rejection is associated with telomere cleavage

      INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    2. Pui, CH; Jeha, S; Irwin, D; Camitta, B
      Recombinant urate oxidase (rasburicase) in the prevention and treatment ofmalignancy-associated hyperuricemia in pediatric and adult patients: results of a compassionate-use trial

      LEUKEMIA
    3. Kurzrock, R; Cortes, J; Thomas, DA; Jeha, S; Pilat, S; Talpaz, M
      Pilot study of low-dose interleukin-11 in patients with bone marrow failure

      JOURNAL OF CLINICAL ONCOLOGY
    4. Chan, KW; Li, CK; Worth, LL; Chik, KW; Jeha, S; Shing, MK; Yuen, PM
      A fludarabine-based conditioning regimen for severe aplastic anemia

      BONE MARROW TRANSPLANTATION
    5. Jeha, S
      Tumor lysis syndrome

      SEMINARS IN HEMATOLOGY
    6. Vey, N; Giles, FJ; Kantarjian, H; Smith, TL; Beran, M; Jeha, S
      The topoisomerase I inhibitor DX-8951f is active in a severe combined immunodeficient mouse model of human acute myelogenous leukemia

      CLINICAL CANCER RESEARCH
    7. Jeha, S; Chan, KW; Aprikyan, AG; Hoots, WK; Culbert, S; Zietz, H; Dale, DC
      Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropenia

      BLOOD
    8. BERAN M; CAO XB; ESTROV Z; JEHA S; JIN GZ; OBRIEN S; TALPAZ M; ARLINGHAUS RB; LYDON NB; KANTARJIAN H
      SELECTIVE-INHIBITION OF CELL-PROLIFERATION AND BCR-ABL PHOSPHORYLATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS EXPRESSING M-R-190,000 BCR-ABLPROTEIN BY A TYROSINE KINASE INHIBITOR (CGP-57148)

      Clinical cancer research
    9. MULLEN CA; PETROPOULOS D; RYTTING M; JEHA S; ZIPF T; ROBERTS WM; ROLSTON KV
      ACUTE REVERSIBLE ARTHROPATHY IN A PEDIATRIC-PATIENT WITH CANCER TREATED WITH A SHORT-COURSE OF CIPROFLOXACIN FOR FEBRILE NEUTROPENIA

      Journal of pediatric hematology/oncology
    10. Jeha, S; Kantarjian, H; O'Brien, S; Vitek, L; Beran, M
      Activity of oral and intravenous 9-aminocamptothecin in SCID mice engrafted with human leukemia

      LEUKEMIA & LYMPHOMA
    11. BERAN M; JEHA S; OBRIEN S; ESTEY E; VITEK L; ZURLO MG; RIOS MB; KEATING M; KANTARJIAN H
      TALLIMUSTINE, AN EFFECTIVE ANTILEUKEMIC AGENT IN A SEVERE COMBINED IMMUNODEFICIENT MOUSE MODEL OF ADULT MYELOGENOUS LEUKEMIA, INDUCES REMISSIONS IN A PHASE-I STUDY

      Clinical cancer research
    12. CANPOLAT C; JEHA S; LOCKHART S; RAMIREZ I; ZIPF T; PINKEL D
      HIGH-DOSE MERCAPTOPURINE AND INTERMEDIATE-DOSE CYTARABINE DURING FIRST REMISSION OF ACUTE MYELOID-LEUKEMIA

      Cancer investigation
    13. BERAN M; CAO X; ESTROV Z; JEHA S; JIN G; OBRIEN S; TALPAZ M; ARLINGHAUS RB; LYDON MB; KANTARJIAN H
      SELECTIVE-INHIBITION OF CELL-PROLIFERATION AND BCR-ABL PHOSPHORYLATION IN ACUTE LYMPHOBLASTIC-LEUKEMIA CELLS EXPRESSING 190-KD BCR-ABL PROTEIN BY A TYROSINE KINASE INHIBITOR (CGP-57148)

      Blood
    14. PALUCKA AK; SCUDERI R; PORWIT A; JEHA S; GRUBER A; BJORKHOLM M; BERAN M; PISA P
      ACUTE LYMPHOBLASTIC LEUKEMIAS FROM RELAPSE ENGRAFT MORE RAPIDLY IN SCID MICE

      Leukemia
    15. OBRIEN S; JEHA S; KANTARJIAN H; PISA P; JIN G; KEATING M; BERAN M
      ENGRAFTMENT OF CHRONIC PROLYMPHOCYTIC AND T-CELL LEUKEMIA IN SCID MICE

      Leukemia
    16. JEHA S; LUO XN; BERAN M; KANTARJIAN H; ATWEH GF
      ANTISENSE RNA INHIBITION OF PHOSPHOPROTEIN P18 EXPRESSION ABROGATES THE TRANSFORMED PHENOTYPE OF LEUKEMIC-CELLS

      Cancer research
    17. BERAN M; JEHA S; OBRIEN S; ESTEY E; VITEK L; ZURLO M; RIOS MB; KEATING M; KANTARJIAN H
      TALLIMUSTINE, AN EFFECTIVE ANTILEUKEMIC AGENT IN A SCID MOUSE MODEL OF ADULT MYELOGENOUS LEUKEMIA (AML), INDUCES REMISSIONS IN A PHASE STUDY

      Blood
    18. JEHA S; KANTARJIAN H; OBRIEN S; HUH Y; PISA P; ORDONEZ N; BERAN M
      GROWTH AND BIOLOGIC PROPERTIES OF KARYOTYPICALLY DEFINED SUBCATEGORIES OF ADULT ACUTE LYMPHOCYTIC-LEUKEMIA IN MICE WITH SEVERE COMBINED IMMUNODEFICIENCY

      Blood
    19. VADHANRAJ S; BROXMEYER HE; JEHA S; ESTEY E; ANDREEFF M; THOMPSON P; TRAHANRIEGER P; GARRISON L
      EFFECTS OF PIXY321 (GM-CSF IL-3 FUSION PROTEIN) IN PATIENTS (PTS) WITH MYELODYSPLASTIC SYNDROMES (MDS)/

      Blood
    20. LOCKHART S; PLUNKETT W; JEHA S; RAMIREZ I; ZIPF T; CORK A; PINKEL D
      HIGH-DOSE MERCAPTOPURINE FOLLOWED BY INTERMEDIATE-DOSE CYTARABINE IN RELAPSED ACUTE-LEUKEMIA

      Journal of clinical oncology
    21. MOORE DF; ANDREEFF M; MAHADEVIA R; VAN N; ZHAO S; GOODACRE A; JEHA S; VADHANRAJ S
      EFFECTS OF THE FUSION PROTEIN PIXY321 ON THE PROLIFERATION OF BONE-MARROW CELLS IN PATIENTS WITH DIAMOND-BLACKFAN ANEMIA

      Blood
    22. JEHA S; OBRIEN S; KANTARJIAN M; ORDONEZ NG; PISA P; TALPAZ M; BERAN M
      GROWTH OF KARYOTYPICALLY DEFINED SUBCATEGORIES OF AML CELLS FROM UNTREATED PATIENTS IN SCID MICE

      Blood
    23. VADHANRAJ S; JEHA S; BROXMEYER HE; HITTELMAN WN; THOMPSON P; ARCENAS A; HOOTS WK; ESTEY E; GARRISON L
      STIMULATION OF HEMATOPOIESIS BY PIXY321 (GM-CSF IL-3 FUSION PROTEIN) IN PATIENTS WITH BONE-MARROW FAILURE/

      Blood
    24. BERAN M; JEHA S; OBRIEN S; PISA P; KANTARJIAN M
      THE SUITABILITY OF THE SCID MOUSE MODEL OF HUMAN ACUTE MYELOGENOUS LEUKEMIA FOR EVALUATION OF ACTIVITY OF NEW ANTILEUKEMIA AGENTS

      Blood
    25. JEHA S; KANTARJIAN H; OBRIEN S; HUH Y; PISA P; STEPHENS L; ORDONEZ N; BERAN M
      GROWTH OF PRIMARY HUMAN ACUTE LYMPHOCYTIC-LEUKEMIA IN SEVERE COMBINEDIMMUNODEFICIENT MICE

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/10/20 alle ore 14:17:31